Anthrax-rPA: Safety, Tolerability, Immunogenicity

NCT00063843 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

NIH

Sponsor class

Conditions

Anthrax

Interventions

BIOLOGICAL: Recombinant Protective Antigen, Anthrax Vaccine Adsorbed

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)